SCHEMBL1024082

SCHEMBL1024082

C=NN1CCOCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20412519 0.85 ALDH1A1 (0.36)
SCHEMBL11917710 0.75
SCHEMBL12311392 0.69
N-Nitrosomorpholine SCHEMBL26048320 0.69
SCHEMBL2571415 0.69
SCHEMBL3535851 0.69
N-Nitrosomorpholine SCHEMBL1578515 0.69
SCHEMBL6871661 0.69
N-Nitrosomorpholine SCHEMBL27520827 0.69 CA12 (0.39)
SCHEMBL14276072 0.65 SMN1; SMN2 (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113200974-A Pharmaceutical composition, furaltadone hydrochloride and preparation method and application method thereof 衢州伟荣药化有限公司 2021-08-03 CN claimed
US-5914351-A Anti-viral aromatic hydrazones UNIROYAL CHEMICAL COMPANY, INC. (US) 1999-06-22 US claimed
CN-113200974-A Pharmaceutical composition, furaltadone hydrochloride and preparation method and application method thereof 衢州伟荣药化有限公司 2021-08-03 CN disclosed
US-20200308163-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF TLR SIGNALING NEUROPORE THERAPIES, INC. (US) 2020-10-01 US disclosed
EP-2121639-B1 SUBSTITUTED 2,4-DIAMINO-1,3,5-TRIAZINES, METHODS FOR THE PRODUCTION THEREOF, AND USE THEREOF AS HERBICIDES AND PLANT GROWTH REGULATORS BAYER CROPSCIENCE AG (DE) 2013-10-16 EP disclosed
US-8513235-B2 Homocysteine synthase inhibitor MITSUBISHI TANABE PHARMA CORPORATION (JP) 2013-08-20 US disclosed
EP-2486925-A1 THERAPEUTIC AGENT FOR CEREBRAL INFARCTION Mitsubishi Tanabe Pharma Corporation (JP) 2012-08-15 EP disclosed
US-20120196824-A1 THERAPEUTIC AGENT FOR CEREBRAL INFARCTION MITSUBISHI TANABE PHARMA CORPORATION (JP) 2012-08-02 US disclosed
US-20110034440-A1 HOMOCYSTEINE SYNTHASE INHIBITOR MITSUBISHI TANABE PHARMA CORPORATION (JP) 2011-02-10 US disclosed
EP-2275404-A1 HOMOCYSTEINE SYNTHASE INHIBITOR Mitsubishi Tanabe Pharma Corporation (JP) 2011-01-19 EP disclosed
EP-2121639-A2 SUBSTITUTED 2,4-DIAMINO-1,3,5-TRIAZINES, METHODS FOR THE PRODUCTION THEREOF, AND USE THEREOF AS HERBICIDES AND PLANT GROWTH REGULATORS Bayer CropScience AG (DE) 2009-11-25 EP disclosed
EP-1149094-B1 4-(AMINOALKOXY)BENZOFURANS AS N-MYRISTOYLTRANSFERASE INHIBITORS BASILEA PHARMACEUTICA AG (CH) 2004-04-21 EP disclosed
US-6376491-B1 BENZOFURAN DERIVATIVES FOR TREATMENT OR PREVENTION OF MYCOSIS IN MAMMALS BASILEA PHARMACEUTICA AG (CH) 2002-04-23 US disclosed
EP-1149094-A2 4-(AMINOALKOXY)BENZOFURANS AS N-MYRISTOYLTRANSFERASE INHIBITORS Basilea Pharmaceutica AG (CH) 2001-10-31 EP disclosed
WO-2000037464-A2 4-(AMINOALKOXY)BENZOFURANS AS N-MYRISTOYLTRANSFERASE INHIBITORS BASILEA PHARMACEUTICA AG (CH) 2000-06-29 WO disclosed
US-5914351-A Anti-viral aromatic hydrazones UNIROYAL CHEMICAL COMPANY, INC. (US) 1999-06-22 US disclosed
US-4743619-A RIFAMYCINS, POLYMERASE INHIBITION AMERICAN HOME PRODUCTS CORPORATION (US) 1988-05-10 US disclosed
WO-1987001280-A1 METHOD OF TREATING HEPATITIS AMERICAN HOME PRODUCTS CORPORATION (US) 1987-03-12 WO disclosed
EP-0213935-A2 Rifamycin derivatives for treating hepatitis AMERICAN HOME PRODUCTS CORPORATION (US) 1987-03-11 EP disclosed
US-4631290-A RIFAMYCINS AMERICAN HOME PRODUCTS CORPORATION (US) 1986-12-23 US disclosed